Products

What will AGI do for Amlodipine besilate?

This classification denotes a calcium channel blocker with the molecular formula C20H25ClN2O5.C6H6O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 864V2Q084H, chemically known as 3,5-pyridinedicarboxylic acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl ester but more generally known as amlodipine besilate, which bears US NIH Compound Identifier 2162. European Medicines Agency schedules Amlodipine besilate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB12864MIG. Most nations, for tariff and trade purposes, schedule amlodipine besilate under HS 29333999 and SITC 51574. SMILES: CCOC(=O)C1=C(NC(=C(C1C2CCCCC2CL)C(=O)OC)C)COCCN.C1CCC(CC1)S(=O)(=O)O.

How AGI delivers it

Four ways AGI delivers for Amlodipine besilate

  • Headless SaaS for Agents

    Give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

    For Amlodipine besilate, give your tools an agent-consumable surface (API / MCP / SDK) so agents can do the work.

  • Services-as-Software

    Get the professional outcome delivered as software, priced on results, not headcount.

    For Amlodipine besilate, get the professional outcome delivered as software, priced on results, not headcount.

Value flow

How Amlodipine besilate connects

measured by

  • Assay Puritymodel
  • Chromatographic Impurity Profilemodel
  • Impurity Contentmodel
  • Loss On Dryingmodel
  • Particle Size Distributionmodel
  • Residual Solventmodel